OrbiMed Israel GP II, 10% Owner: Damora Therapeutics DMRA Sell · Filed 23/08/17

Trade details

Type: Insider sale
Amount: $401,650.5
Shares · price: 535,534 sh · $0.75 a share
Held after: 1,510,375 sh
Stock: Damora Therapeutics DMRA
Person: OrbiMed Israel GP II10% Owner
Trade date: 23/08/15
Filed: 23/08/17
Days to filing: 2 days

Sold 26.2% of holdings

Share of holding sold: 26.2%

Damora Therapeutics trades, last 26 weeks

What else happened in Damora Therapeutics around then

Filed or reported within 30 days of the trade day · 23/07/16~23/09/14

OrbiMed Israel GP II's recent trades

OrbiMed Israel GP IIDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
OrbiMed Israel GP IIDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
OrbiMed Israel GP IIDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
OrbiMed Israel GP II10% Owner
SellAdicet Bio
Sell
Adicet Bio
ACET
$263.5K
40,416 sh
$263.5K
Filed 04/09
Traded 04/08
OrbiMed Israel GP II10% Owner
SellAdicet Bio
Sell
Adicet Bio
ACET
$204.6K
32,523 sh
$204.6K
Filed 04/09
Traded 04/08